EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF SIALORRHEA: RESULTS OF THE MAIN PHASE OF A PHASE 3 STUDY

被引：0

作者：

Jost, Wolfgang H. ^{[1
]}

Michel, Olaf ^{[2
]}

Oehlwein, Christian ^{[3
]}

Slawek, Jaroslaw ^{[4
,5
]}

Bogucki, Andrzej ^{[6
]}

Ochudlo, Stanislaw ^{[7
,8
]}

Banach, Marta ^{[9
]}

Pagan, Fernando ^{[10
]}

Flatau-Baque, Birgit ^{[11
]}

Csikos, Janos ^{[11
]}

Blitzer, Andrew ^{[12
]}

机构：

[1] Parkinson Klin Ortenau, Wolfach, Germany

[2] Vrije Univ Brussel, Univ Hosp Brussels, Dept Otorhinolcuyngol, Brussels, Belgium

[3] Neurol Outpatient Clin Parkinson Dis & Deep Brain, Gera, Germany

[4] Med Univ Gdansk, Dept Neurol Psychiat Nursing, Gdansk, Poland

[5] St Adalbert Hosp, Dept Neurol, Gdansk, Poland

[6] Med Univ Lodi, Dept Extrapyramidal Dis, Lodi, Italy

[7] Med Univ Silesia, Dept Neurol, Katowice, Poland

[8] Med Univ Silesia, Stroke Unit, Katowice, Poland

[9] Jagiellonian Univ, Dept Neurol, Coll Med, Krakow, Poland

[10] Georgetown Univ, Dept Neurol, Washington, DC USA

[11] Merz Pharmaceut GmbH, Frankfurt, Germany

[12] Columbia Univ Coll Phys & Surg, Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, Dept Neurol,New York Ctr Voice & Swallowing Disor, New York, NY USA

来源：

TOXICON | 2018年 / 156卷

关键词：

Botulinum toxin; IncobotulinumtoxinA; Parkinson's disease; Sialorrhea; SIAXI; Stroke;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

116

引用

页码：S53 / S53

页数：1

共 50 条

[1] Long-term Efficacy and Safety of IncobotulinumtoxinA Treatment for Sialorrhea
Pagan, Fernando
Jost, Wolfgang H.
Oehlwein, Christian
Slawek, Jaroslaw
Bogucki, Andrzej
Ochudlo, Stanislaw
Banach, Marta
Csikos, Janos
Blitzer, Andrew
[J]. NEUROLOGY, 2019, 92 (15)
[2] LONG-TERM EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA
Pagan, Fernando
Jost, Wolfgang H.
Michel, Olaf
Oehlwein, Christian
Slawek, Jaroslaw
Bogucki, Andrzej
Ochudlo, Stanislaw
Banach, Marta
Flatau-Baque, Birgit
Csikos, Janos
Blitzer, Andrew
[J]. TOXICON, 2018, 156 : S86 - S87
[3] SIAXI: Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: results of a Phase III, placebo-controlled, randomised, doubleblind study
Csikos, J.
Blitzer, A.
Friedman, A.
Michel, O.
Flatau-Baque, B.
Jost, W.
[J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 12 - 12
[4] LONG-TERM SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF BLEPHAROSPASM IN BOTULINUM TOXIN-NAIVE SUBJECTS: RESULTS OF A PHASE 3 STUDY
Mitsikostas, Dimos D.
Dekundy, Andrzej
Sternberg, Kati
Althaus, Michael
Pagan, Fernando
[J]. TOXICON, 2018, 156 : S81 - S82
[5] IMPACT OF INJECTION GUIDANCE TECHNIQUES ON THE EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA FOR SIALORRHEA
Jost, W.
Pagan, F.
Michel, O.
Oehlwein, C.
Slawek, J.
Bogucki, A.
Ochudlo, S.
Banach, M.
Flatau-Baque, B.
Csikos, J.
Blitzer, A.
[J]. PARKINSONISM & RELATED DISORDERS, 2023, 113 : 41 - 41
[6] Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea
Pagan, F.
Jost, W.
Friedman, A.
Michel, O.
Oehlwein, C.
Slawek, J.
Bogucki, A.
Ochudlo, S.
Banach, M.
Flatau-Baque, B.
Csikos, J.
Blitzer, A.
[J]. MOVEMENT DISORDERS, 2018, 33 : S756 - S756
[7] IMPACT OF INJECTION GUIDANCE TECHNIQUES ON THE EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA FOR SIALORRHEA
Pagan, Fernando
Jost, Wolfgang H.
Michel, Olaf
Oehlwein, Christian
Slawek, Jaroslaw
Bogucki, Andrzej
Ochudlo, Stanislaw
Banach, Marta
Flatau-Baque, Birgit
Csikos, Janos
Blitzer, Andrew
[J]. TOXICON, 2018, 156 : S87 - S87
[8] SIAXI: INCOBOTULINUMTOXINA FOR SIALORRHEA IN PARKINSON'S DISEASE, STROKE, AND OTHER ETIOLOGIES-PHASE 3 RESULTS
Jost, Wolfgang
Friedman, Andrzej
Michel, Olaf
Flatau-Baque, Birgit
Hast, Michael
Csikos, Janos
Blitzer, Andrew
[J]. MUSCLE & NERVE, 2018, 58 : S57 - S57
[9] SIAXI: IncobotulinumtoxinA for sialorrhea in Parkinson's disease, stroke, and other etiologies-Phase 3 Results
Blitzer, Andrew
Friedman, Andrzej
Michel, Olaf
Flatau-Baque, Birgit
Csikos, Janos
Jost, Wolfgang
[J]. NEUROLOGY, 2018, 90
[10] EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA IN THE TREATMENT OF UPPER FACIAL LINES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY
Kerscher, Martina
Rzany, Berthold
Prager, Welf
Trevidic, Patrick
Inglefield, Christopher
[J]. TOXICON, 2018, 156 : S60 - S60

← 1 2 3 4 5 →